JP2019509717A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509717A5
JP2019509717A5 JP2018538718A JP2018538718A JP2019509717A5 JP 2019509717 A5 JP2019509717 A5 JP 2019509717A5 JP 2018538718 A JP2018538718 A JP 2018538718A JP 2018538718 A JP2018538718 A JP 2018538718A JP 2019509717 A5 JP2019509717 A5 JP 2019509717A5
Authority
JP
Japan
Prior art keywords
residue
amino acid
polymerase
position corresponding
acid substitution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018538718A
Other languages
English (en)
Japanese (ja)
Other versions
JP6934477B2 (ja
JP2019509717A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/014082 external-priority patent/WO2017127510A2/en
Publication of JP2019509717A publication Critical patent/JP2019509717A/ja
Publication of JP2019509717A5 publication Critical patent/JP2019509717A5/ja
Priority to JP2021135313A priority Critical patent/JP7256849B2/ja
Application granted granted Critical
Publication of JP6934477B2 publication Critical patent/JP6934477B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018538718A 2016-01-19 2017-01-19 熱安定逆転写酵素 Active JP6934477B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021135313A JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662280451P 2016-01-19 2016-01-19
US62/280,451 2016-01-19
PCT/US2017/014082 WO2017127510A2 (en) 2016-01-19 2017-01-19 Thermostable reverse transcriptase

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021135313A Division JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Publications (3)

Publication Number Publication Date
JP2019509717A JP2019509717A (ja) 2019-04-11
JP2019509717A5 true JP2019509717A5 (cg-RX-API-DMAC7.html) 2020-02-27
JP6934477B2 JP6934477B2 (ja) 2021-09-15

Family

ID=59362774

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018538718A Active JP6934477B2 (ja) 2016-01-19 2017-01-19 熱安定逆転写酵素
JP2021135313A Active JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021135313A Active JP7256849B2 (ja) 2016-01-19 2021-08-23 熱安定逆転写酵素

Country Status (4)

Country Link
US (3) US10323243B2 (cg-RX-API-DMAC7.html)
EP (2) EP3405578B1 (cg-RX-API-DMAC7.html)
JP (2) JP6934477B2 (cg-RX-API-DMAC7.html)
WO (1) WO2017127510A2 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10323243B2 (en) 2016-01-19 2019-06-18 Board Of Regents, The University Of Texas System Thermostable reverse transcriptase
EP3720606A4 (en) * 2017-07-27 2021-05-05 Board Of Regents, The University Of Texas System AMPLIFICATION OF PAIRED PROTEINCODING MRNA SEQUENCES
WO2019084538A1 (en) * 2017-10-27 2019-05-02 Board Of Regents, The University Of Texas System TUMOR SPECIFIC ANTIBODIES, T CELL RECEPTORS AND METHODS OF IDENTIFICATION THEREOF
CN114174503B (zh) * 2019-07-26 2024-06-28 东洋纺株式会社 稳定性优异的突变型逆转录酶
WO2024238992A1 (en) * 2023-05-18 2024-11-21 10X Genomics, Inc. Engineered non-strand displacing family b polymerases for reverse transcription and gap-fill applications
CN117778348B (zh) * 2023-12-12 2024-09-20 湖北大学 一种具有逆转录酶活性的Pfu DNA聚合酶突变体及其应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030228616A1 (en) * 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
US20040009486A1 (en) 1999-10-29 2004-01-15 Sorge Joseph A. Compositions and methods utilizing DNA polymerases
EP1154017B1 (en) * 2000-05-11 2010-01-20 Toyo Boseki Kabushiki Kaisha Modified thermostable dna polymerase from pyrococcus kodakarensis
GB0022458D0 (en) 2000-09-13 2000-11-01 Medical Res Council Directed evolution method
US20030134292A1 (en) 2001-10-30 2003-07-17 Farchaus Joseph W. Thermostable DNA polymerases and methods of making same
EP1452593B1 (en) * 2001-11-14 2009-04-08 Toyo Boseki Kabushiki Kaisha Dna synthesis promoters, dna polymerase-associated factors and utilization thereof
US7932070B2 (en) * 2001-12-21 2011-04-26 Agilent Technologies, Inc. High fidelity DNA polymerase compositions and uses therefor
US7148049B2 (en) * 2002-04-02 2006-12-12 Roche Molecular Systems, Inc. Thermostable or thermoactive DNA polymerase molecules with attenuated 3′-5′ exonuclease activity
DK2145956T3 (da) 2003-11-03 2015-09-21 Medical Res Council Polymerase
GB0325653D0 (en) 2003-11-03 2003-12-10 Medical Res Council CST emulsions
US20070048748A1 (en) * 2004-09-24 2007-03-01 Li-Cor, Inc. Mutant polymerases for sequencing and genotyping
WO2008029085A2 (en) 2006-09-06 2008-03-13 Medical Research Council Polymerase
EP2076592B1 (en) 2006-10-23 2017-04-12 Medical Research Council Polymerase
WO2010062776A2 (en) 2008-11-03 2010-06-03 Kapabiosystems Chimeric dna polymerases
US20110301041A1 (en) * 2010-02-26 2011-12-08 Life Technologies Corporation Modified Proteins and Methods of Making and Using Same
GB201007384D0 (en) * 2010-04-30 2010-06-16 Medical Res Council Enzymes
US10323243B2 (en) 2016-01-19 2019-06-18 Board Of Regents, The University Of Texas System Thermostable reverse transcriptase

Similar Documents

Publication Publication Date Title
WO2015196150A3 (en) Mutations that confer genetic stability to additional genes in influenza viruses
MX2019006943A (es) Polipéptidos para manejo de infecciones virales.
FI3526323T3 (fi) Hepatiitti B -viruksen genomissa oleville tunnistussekvensseille spesifisiä muokattuja meganukleaaseja
MX2020013278A (es) Analogos de nucleotidos.
EP4397757A3 (en) Rna polymerase variants
JP2015154787A5 (cg-RX-API-DMAC7.html)
FR2981088B1 (fr) Arn polymerases mutees
MY197236A (en) 2'-substituted-n6-substituted purine nucleotides for rna virus treatment
WO2015155686A3 (en) Methods and compositions for rna-directed repression of transcription using crispr-associated genes
EP4659816A3 (en) MODIFIED CAPSID PROTEINS FOR IMPROVED PARVOVIRUS VECTOR DELIVERY
EA038402B9 (ru) Аденовирусные полинуклеотиды и полипептиды
NZ714415A (en) Substituted nucleosides, nucleotides and analogs thereof
JP2017518750A5 (cg-RX-API-DMAC7.html)
WO2014202616A3 (en) Rasamsonia gene and use thereof
NZ594355A (en) Simian adenovirus nucleic acid- and amino acid-sequences, vectors containing same, and uses thereof
WO2016046234A3 (en) Recombinant phe-free proteins for use in the treatment of phenylketonuria
EP3252172A3 (en) Fast hybridization for next generation sequencing target enrichment
MY194351A (en) Recombinant Human-Basic Fibroblast Growth Factor (Rh-Bfgf) and Pharmaceutical Composition Comprising Rh-Bfgf
MD4760B1 (ro) Compoziţii şi metode de tratament al infecţiilor provocate de viruşii hepatitei B şi hepatitei D
WO2020109780A3 (en) Polypeptide and uses thereof
PH12017550134A1 (en) Il-37 variants
DK4069729T3 (da) Optimerede, modificerede meganukleaser med specificitet for en genkendelsessekvens i hepatitis b-virusgenomet
WO2017021471A8 (en) Methods for amplifying and sequencing the genome of a hepatitis c virus
MX2018003162A (es) Variante en el numero de copias que genera resistencia a virus.
EP4043558A3 (en) Kaurenoic acid hydroxylases